(Q28115209)

3 January 2017

title

Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability (English)

1 reference

pancreatic adenocarcinoma

3 January 2017

0 references

1 reference

1 reference

1 reference

S. J. Kim

1

1 reference

3 January 2017

Y. Lee

2

1 reference

3 January 2017

N. Y. Kim

3

1 reference

3 January 2017

Y. Hwang

4

1 reference

3 January 2017

B. Hwang

5

1 reference

3 January 2017

J.-K. Min

6

1 reference

3 January 2017

S. S. Koh

7

1 reference

3 January 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

3 January 2017

1 reference

3 January 2017

volume

32

1 reference

3 January 2017

issue

31

1 reference

3 January 2017

page(s)

3638–3647

1 reference

Tumorigenesis and the angiogenic switch

3 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Crystal structures of human secretory proteins ZG16p and ZG16b reveal a Jacalin-related β-prism fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Tumor metastasis: mechanistic insights and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

The role of adherens junctions and VE-cadherin in the control of vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Targeting angiogenesis in pancreatic cancer: rationale and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Pathways for aberrant angiogenesis in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Prognostic significance of angiogenesis in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Transcriptional anti-angiogenesis therapy of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Pancreatic cancer: molecular pathogenesis and new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

IL-1 is required for tumor invasiveness and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

VEGF-A and the induction of pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Pathophysiological consequences of VEGF-induced vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Role of growth factors in pancreatic cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Proinflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366

The Chemokine SDF-1/CXCL12 Contributes to T Lymphocyte Recruitment in Human Pre-ovulatory Follicles and Coordinates with Lymphocytes to Increase Granulosa Cell Survival and Embryo Quality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.366